HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 257.40 billion as of June 27, 2025. Its market cap has increased by 16.75% in one year.

Market Cap

257.40B

Enterprise Value

n/a

Revenue

36.10B

Ranking

n/a

PE Ratio

544.57

Stock Price

16,860.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 257.40B, an increase of 205.40%. That is a compound annual growth rate of 12.47%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	257.40B	-23.94%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	240.12B	219.34%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.46T
Celltrion	35.49T
ALTEOGEN	20.84T
Yuhan	7,589.05B
SK Biopharmaceuticals	7,236.14B
HLB Co., Ltd.	6,512.41B
PharmaResearch	4,992.23B
Peptron	4,741.01B

Market Cap Rankings